Aortic valve bioprosthesis PERIMOUNT Magna

bovine tissue

Magna valve Carpentier-Edwards PERIMOUNT Magna aortic heart valve The Magna valve (bioprosthesis) has a true supra-annular design for optimal hemodynamics and flow characteristics. Enables up to 23% greater effective orifice area (EOA)** Demonstrates exceptional hemodynamic performance with a very low risk of patient-prosthesis mismatch30 Designed on the foundation of the PERIMOUNT aortic valve, with published clinical durability of up to 20 years Treated with the Carpentier-Edwards ThermaFix process, which confronts both major calcium binding sites: residual glutaraldehydes and phospholipids‡ Design Mathematically modeled, bioengineered design - optimized for hemodynamics, durability and implantability Flexible cobalt-chromium alloy stent - absorbs energy to reduce leaflet stress Three independent bovine pericardial leaflets - matched for thickness and elasticity to optimize stress distribution Indications The Carpentier-Edwards PERIMOUNT Magna pericardial aortic bioprosthesis is intended for use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. It is also intended for use in patients with a previously implanted aortic valve prosthesis that is no longer functioning adequately and requires replacement. In the latter case, the previously implanted prosthesis is surgically excised and replaced by the replacement prosthesis. Materials list Valve leaflets: Bovine pericardium Stent: Cobalt-chromium alloy Fabric covering stent: Polyester cloth Valve sewing ring: Silicone rubber